Biotechnology Assets, S.A. (BST:041)

Market Cap	17.46M -19.1%
Revenue (ttm)	3.05M -9.5%
Net Income	-2.08M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.2230
Previous Close	n/a
Day's Range	0.2170 - 0.2240
52-Week Range	0.1130 - 0.5240
Beta	n/a
RSI	55.03
Earnings Date	Apr 14, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer...

• Industry: Pharmaceutical Preparations
• CEO: Jaime Feced Rubio
• Employees: 30
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 041